Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience

The long‐term effects of tyrosine kinase inhibitors (TKIs), including imatinib, and surgical intervention on advanced gastrointestinal stromal tumor (GIST) were evaluated. All 379 patients had metastatic or recurrent GIST and started 400 mg/d imatinib at the Asan Medical Center in periods 1 and 2 [2...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Kim, Jwa Hoon, Ryu, Min‐Hee, Yoo, Changhoon, Chae, Heejung, Na, Hana, Beck, Moyoul, Kim, Beom Su, Yoo, Moon‐Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Ki‐Hun, Kim, Chan Wook, Kang, Yoon‐Koo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434201/
https://ncbi.nlm.nih.gov/pubmed/30693663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1994
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak